Speaker

Shirish A. Shah

Dr. Shirish A. Shah

Chief Scientific Officer, Development and Regulatory Affairs
EZRA Pharma, LLC
India

Dr. Shah, currently as Chief Scientific Officer at EZRA Pharma(US) earned BPharm-BUDCT(Mumbai), MS Pharmaceutics-Connecticut(US) and PhD-Iowa(US) and holds RAC of RAPS(US). He is featured in US-Marquis Who’sWho in America; World; Medicine and Healthcare and Science and Engineering also holds 15 US/EU Patents covering complex formulations/technologies. 

Currently at EZRA (6-years), he held 40-years’ leadership positions in US at ICON, 3-divisions of TEVA, Perrigo, Allergan, CIBA and DuPont, encompassing NCEs; 505(b)(2) NDAs and ANDAs with credentials of successful development of over 150 Generic and NDA Products taking from concepts to commercialization. He filed several First-To-File (FTF) and Para-IV ANDAs and given depositions.

DAY III - FRIDAY 10TH JANUARY, 2020

4:00 pm to 5:30 pm

BT XV: Generics to Complex Generics to Super Generics - The Reality and the Way Forward

Le Meridien

Know More